8-K 1 gthp8k52810.htm GUIDED THERAPEUTICS, INC. gthp8k52810.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (May 28, 2010):  May 27, 2010
 
GUIDED THERAPEUTICS, INC.
 (Exact Name of Registrant as Specified in Its Charter)
 
         
Delaware
(State or Other Jurisdiction of Incorporation)
  
0-22179
(Commission File Number)
  
58-2029543
(IRS Employer Identification No.)

   
5835 Peachtree Corners East, Suite D
Norcross, Georgia
(Address of Principal Executive Offices)
30092
(Zip Code)
 
Registrant's Telephone Number, Including Area Code:     (770) 242-8723
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions :
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
 
 
 
 
 
 
 
 

 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
On May 27, 2010, the Company held its annual meeting of stockholders in Norcross, Georgia.  As of the record date, March 31, 2010, there were 38,160,388 shares of Common Stock entitled to vote at the annual meeting. Represented at the meeting in person or by proxy were 30,306,067 shares representing 79.42% of the total shares of Common Stock entitled to vote at the meeting.

The purpose of the meeting was to elect seven directors to a one-year term expiring in 2011; to approve and adopt an amendment to the Company’s 1995 Stock Plan, as amended, increasing the number of shares available for grant by 1.8 million shares; and, to ratify the appointment of UHY LLP as the Company’s independent registered public accounting firm for the 2010 fiscal year. The following table sets forth the results of the vote on the matter:

Directors
    
MARK L FAUPEL PH D
For
17,180,307
 
Withheld
2,083,506
WILLIAM E ZACHARY JR
For
17,183,807
 
Withheld
2,080,006
JOHN E IMHOFF M D
For
17,186,307
 
Withheld
2,077,506
MICHAEL C JAMES
For
17,186,807
 
Withheld
2,077,006
RONALD W HART PH D
For
17,183,807
 
Withheld
2,080,006
RONALD W ALLEN
For
17,056,448
 
Withheld
2,207,365
JONATHAN M NILOFF M D
For
17,173,307
 
Withheld
2,090,506
     
To approve and adopt an amendment to the Company’s 1995 Stock Plan, as amended, increasing the number of shares available for grant by 1.8 million shares.
For
15,894,886
 
Against
3,295,749
 
Abstain
73,178
 
Broker Non Votes
11,042,254
     
     
To ratify the appointment of UHY LLP as the Company’s independent registered public accounting firm for the 2010 fiscal year.
For
28,029,149
 
Against
2,056,323
 
Abstain
220,595
 
Broker Non Votes
0




 
 
 
2
 


 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
     GUIDED THERAPEUTICS, INC  
       
   By:  /s/ MARK L. FAUPEL  
                                                                                                                                                                                                                  Mark L. Faupel, Ph.D.  
     CEO & President  
 Date:  May 28, 2010      
 
 
 
 
 
 
 
 
 
3